Marcin Ziemniak*a,
Sylwia Pawlędzioa,
Anna Zawadzka-Kazimierczuka,
Paulina M. Dominiaka,
Damian Trzybińskia,
Wiktor Koźmińskia,
Rafał Zielińskib,
Izabela Foktb,
Waldemar Priebe*b,
Krzysztof Woźniak*a and
Beata Pająk*c
aBiological and Chemical Research Centre, Department of Chemistry, University of Warsaw, Zwirki i Wigury 101, 02-089 Warszawa, Poland. E-mail: mziemniak@chem.uw.edu.pl; spawledzio@chem.uw.edu.pl; anzaw@chem.uw.edu.pl; dtrzybinski@chem.uw.edu.pl; kozmin@chem.uw.edu.pl; kwozniak@chem.uw.edu.pl
bDepartment of Experimental Therapeutics, The University of Texas MD Anderson Cancer Center, 1901 East Rd., Houston, TX 77054, USA. E-mail: rziel77@gmail.com; ifokt@mdanderson.org; wpriebe@mac.com
cIndependent Laboratory of Genetics and Molecular Biology, Kaczkowski Military Institute of Hygiene and Epidemiology, Kozielska 4, 01-163 Warsaw, Poland. E-mail: bepaj@wp.pl
First published on 1st April 2022
Correction for ‘X-ray wavefunction refinement and comprehensive structural studies on bromo-substituted analogues of 2-deoxy-D-glucose in solid state and solution’ by Marcin Ziemniak et al., RSC Adv., 2022, 12, 8345–8360. DOI: 10.1039/D1RA08312K
The Royal Society of Chemistry apologises for these errors and any consequent inconvenience to authors and readers.
This journal is © The Royal Society of Chemistry 2022 |